{"entity_poly": {"nstd_linkage": "no", "nstd_monomer": "no", "pdbx_seq_one_letter_code": "VTCPEQDKYRTITGMCNNRRSPTLGASNRAFVRWLPAEYEDGFSLPYGWTPGVKRNGFPVALARAVSNEIVRFPTDQLTPDQERSLMFMQWGQLLDHDLDFTPEPAAR", "pdbx_seq_one_letter_code_can": "VTCPEQDKYRTITGMCNNRRSPTLGASNRAFVRWLPAEYEDGFSLPYGWTPGVKRNGFPVALARAVSNEIVRFPTDQLTPDQERSLMFMQWGQLLDHDLDFTPEPAAR", "pdbx_strand_id": "A,B", "rcsb_artifact_monomer_count": 0, "rcsb_conflict_count": 0, "rcsb_deletion_count": 0, "rcsb_entity_polymer_type": "Protein", "rcsb_insertion_count": 0, "rcsb_mutation_count": 0, "rcsb_non_std_monomer_count": 0, "rcsb_sample_sequence_length": 108, "type": "polypeptide(L)"}, "entity_src_nat": [{"common_name": "human", "genus": "Homo", "pdbx_alt_source_flag": "sample", "pdbx_cell": "NEUTROPHIL", "pdbx_ncbi_taxonomy_id": "9606", "pdbx_organelle": "AZUROPHIL GRANULES", "pdbx_organism_scientific": "Homo sapiens", "pdbx_src_id": 1, "tissue": "BLOOD"}], "rcsb_cluster_flexibility": {"avg_rmsd": 0.301, "label": "No", "link": "http://pdbflex.org/cluster.html#!/3f9pA/12966/1mhlA", "max_rmsd": 0.614, "provenance_code": "PDBFlex"}, "rcsb_cluster_membership": [{"cluster_id": 571, "identity": 100}, {"cluster_id": 697, "identity": 95}, {"cluster_id": 746, "identity": 90}, {"cluster_id": 1044, "identity": 70}, {"cluster_id": 728, "identity": 50}, {"cluster_id": 1424, "identity": 30}], "rcsb_entity_source_organism": [{"ncbi_common_names": ["human"], "ncbi_parent_scientific_name": "Eukaryota", "ncbi_scientific_name": "Homo sapiens", "ncbi_taxonomy_id": 9606, "pdbx_src_id": 1, "provenance_source": "Primary Data", "scientific_name": "Homo sapiens", "source_type": "natural", "taxonomy_lineage": [{"depth": 1, "id": "131567", "name": "cellular organisms"}, {"depth": 1, "id": "131567", "name": "biota"}, {"depth": 2, "id": "2759", "name": "Eukaryota"}, {"depth": 2, "id": "2759", "name": "Eucarya"}, {"depth": 2, "id": "2759", "name": "Eucaryotae"}, {"depth": 2, "id": "2759", "name": "Eukarya"}, {"depth": 2, "id": "2759", "name": "Eukaryotae"}, {"depth": 2, "id": "2759", "name": "eukaryotes"}, {"depth": 3, "id": "33154", "name": "Opisthokonta"}, {"depth": 3, "id": "33154", "name": "Fungi/Metazoa group"}, {"depth": 3, "id": "33154", "name": "opisthokonts"}, {"depth": 4, "id": "33208", "name": "Metazoa"}, {"depth": 4, "id": "33208", "name": "Animalia"}, {"depth": 4, "id": "33208", "name": "animals"}, {"depth": 4, "id": "33208", "name": "metazoans"}, {"depth": 4, "id": "33208", "name": "multicellular animals"}, {"depth": 5, "id": "6072", "name": "Eumetazoa"}, {"depth": 6, "id": "33213", "name": "Bilateria"}, {"depth": 7, "id": "33511", "name": "Deuterostomia"}, {"depth": 7, "id": "33511", "name": "deuterostomes"}, {"depth": 8, "id": "7711", "name": "Chordata"}, {"depth": 8, "id": "7711", "name": "chordates"}, {"depth": 9, "id": "89593", "name": "Craniata"}, {"depth": 10, "id": "7742", "name": "Vertebrata"}, {"depth": 10, "id": "7742", "name": "vertebrates"}, {"depth": 11, "id": "7776", "name": "Gnathostomata"}, {"depth": 11, "id": "7776", "name": "jawed vertebrates"}, {"depth": 12, "id": "117570", "name": "Teleostomi"}, {"depth": 13, "id": "117571", "name": "Euteleostomi"}, {"depth": 13, "id": "117571", "name": "bony vertebrates"}, {"depth": 14, "id": "8287", "name": "Sarcopterygii"}, {"depth": 15, "id": "1338369", "name": "Dipnotetrapodomorpha"}, {"depth": 16, "id": "32523", "name": "Tetrapoda"}, {"depth": 16, "id": "32523", "name": "tetrapods"}, {"depth": 17, "id": "32524", "name": "Amniota"}, {"depth": 17, "id": "32524", "name": "amniotes"}, {"depth": 18, "id": "40674", "name": "Mammalia"}, {"depth": 18, "id": "40674", "name": "mammals"}, {"depth": 19, "id": "32525", "name": "Theria"}, {"depth": 20, "id": "9347", "name": "Eutheria"}, {"depth": 20, "id": "9347", "name": "Placentalia"}, {"depth": 20, "id": "9347", "name": "eutherian mammals"}, {"depth": 20, "id": "9347", "name": "placental mammals"}, {"depth": 20, "id": "9347", "name": "placentals"}, {"depth": 21, "id": "1437010", "name": "Boreoeutheria"}, {"depth": 21, "id": "1437010", "name": "Boreotheria"}, {"depth": 22, "id": "314146", "name": "Euarchontoglires"}, {"depth": 23, "id": "9443", "name": "Primates"}, {"depth": 23, "id": "9443", "name": "Primata"}, {"depth": 23, "id": "9443", "name": "primate"}, {"depth": 23, "id": "9443", "name": "primates"}, {"depth": 24, "id": "376913", "name": "Haplorrhini"}, {"depth": 25, "id": "314293", "name": "Simiiformes"}, {"depth": 25, "id": "314293", "name": "Anthropoidea"}, {"depth": 26, "id": "9526", "name": "Catarrhini"}, {"depth": 27, "id": "314295", "name": "Hominoidea"}, {"depth": 27, "id": "314295", "name": "ape"}, {"depth": 27, "id": "314295", "name": "apes"}, {"depth": 28, "id": "9604", "name": "Hominidae"}, {"depth": 28, "id": "9604", "name": "Pongidae"}, {"depth": 28, "id": "9604", "name": "great apes"}, {"depth": 29, "id": "207598", "name": "Homininae"}, {"depth": 29, "id": "207598", "name": "Homo/Pan/Gorilla group"}, {"depth": 30, "id": "9605", "name": "Homo"}, {"depth": 30, "id": "9605", "name": "humans"}, {"depth": 31, "id": "9606", "name": "Homo sapiens"}, {"depth": 31, "id": "9606", "name": "human"}]}], "rcsb_genomic_lineage": [{"depth": 0, "id": "9606", "name": "Homo sapiens"}, {"depth": 1, "id": "9606:17", "name": "Chromosome 17"}, {"depth": 2, "id": "9606:17:myeloperoxidase", "name": "myeloperoxidase"}], "rcsb_polymer_entity": {"details": "ISOFORM C", "formula_weight": 12.332, "pdbx_description": "MYELOPEROXIDASE", "pdbx_ec": "1.11.1.7", "pdbx_number_of_molecules": 2, "rcsb_multiple_source_flag": "N", "rcsb_source_part_count": 1, "rcsb_source_taxonomy_count": 1, "src_method": "nat", "rcsb_ec_lineage": [{"depth": 1, "id": "1", "name": "Oxidoreductases"}, {"depth": 2, "id": "1.11", "name": "Acting on a peroxide as acceptor"}, {"depth": 3, "id": "1.11.1", "name": "Peroxidases"}, {"depth": 4, "id": "1.11.1.7", "name": "peroxidase"}, {"depth": 1, "id": "1", "name": "Oxidoreductases"}, {"depth": 2, "id": "1.11", "name": "Acting on a peroxide as acceptor"}, {"depth": 3, "id": "1.11.2", "name": "Peroxygenases"}, {"depth": 4, "id": "1.11.2.2", "name": "myeloperoxidase"}], "rcsb_macromolecular_names_combined": [{"name": "MYELOPEROXIDASE", "provenance_code": "ECO:0000304", "provenance_source": "PDB Preferred Name"}], "rcsb_enzyme_class_combined": [{"depth": 4, "ec": "1.11.1.7", "provenance_source": "PDB Primary Data"}, {"depth": 4, "ec": "1.11.2.2", "provenance_source": "UniProt"}], "rcsb_polymer_name_combined": {"names": ["Myeloperoxidase"], "provenance_source": "UniProt Name"}}, "rcsb_polymer_entity_align": [{"provenance_source": "SIFTS", "reference_database_accession": "P05164", "reference_database_name": "UniProt", "aligned_regions": [{"entity_beg_seq_id": 1, "length": 108, "ref_beg_seq_id": 165}]}], "rcsb_polymer_entity_annotation": [{"annotation_id": "GO:0042744", "name": "hydrogen peroxide catabolic process", "provenance_source": "UNIPROT", "type": "GO", "annotation_lineage": [{"id": "GO:0009056", "name": "catabolic process"}, {"id": "GO:0042743", "name": "hydrogen peroxide metabolic process"}, {"id": "GO:0072593", "name": "reactive oxygen species metabolic process"}, {"id": "GO:0008150", "name": "biological_process"}, {"id": "GO:0008152", "name": "metabolic process"}, {"id": "GO:0009987", "name": "cellular process"}, {"id": "GO:0042744", "name": "hydrogen peroxide catabolic process"}]}, {"annotation_id": "IPR019791", "name": "Haem peroxidase, animal-type", "provenance_source": "UNIPROT", "type": "InterPro", "annotation_lineage": [{"depth": 1, "id": "IPR019791", "name": "Haem peroxidase, animal-type"}]}, {"annotation_id": "GO:0034374", "name": "low-density lipoprotein particle remodeling", "provenance_source": "UNIPROT", "type": "GO", "annotation_lineage": [{"id": "GO:0071827", "name": "plasma lipoprotein particle organization"}, {"id": "GO:0032501", "name": "multicellular organismal process"}, {"id": "GO:0050789", "name": "regulation of biological process"}, {"id": "GO:0034374", "name": "low-density lipoprotein particle remodeling"}, {"id": "GO:0043933", "name": "protein-containing complex organization"}, {"id": "GO:0034367", "name": "protein-containing complex remodeling"}, {"id": "GO:0071825", "name": "protein-lipid complex organization"}, {"id": "GO:0065007", "name": "biological regulation"}, {"id": "GO:0034369", "name": "plasma lipoprotein particle remodeling"}, {"id": "GO:0097006", "name": "regulation of plasma lipoprotein particle levels"}, {"id": "GO:0016043", "name": "cellular component organization"}, {"id": "GO:0008150", "name": "biological_process"}, {"id": "GO:0034368", "name": "protein-lipid complex remodeling"}, {"id": "GO:0009987", "name": "cellular process"}, {"id": "GO:0071840", "name": "cellular component organization or biogenesis"}]}, {"annotation_id": "GO:0019430", "name": "removal of superoxide radicals", "provenance_source": "UNIPROT", "type": "GO", "annotation_lineage": [{"id": "GO:0051716", "name": "cellular response to stimulus"}, {"id": "GO:0050896", "name": "response to stimulus"}, {"id": "GO:0034599", "name": "cellular response to oxidative stress"}, {"id": "GO:0098754", "name": "detoxification"}, {"id": "GO:0072593", "name": "reactive oxygen species metabolic process"}, {"id": "GO:0062197", "name": "cellular response to chemical stress"}, {"id": "GO:0000303", "name": "response to superoxide"}, {"id": "GO:0098869", "name": "cellular oxidant detoxification"}, {"id": "GO:0071450", "name": "cellular response to oxygen radical"}, {"id": "GO:0034614", "name": "cellular response to reactive oxygen species"}, {"id": "GO:0033554", "name": "cellular response to stress"}, {"id": "GO:0006950", "name": "response to stress"}, {"id": "GO:0008150", "name": "biological_process"}, {"id": "GO:1990748", "name": "cellular detoxification"}, {"id": "GO:1901700", "name": "response to oxygen-containing compound"}, {"id": "GO:1901701", "name": "cellular response to oxygen-containing compound"}, {"id": "GO:0000302", "name": "response to reactive oxygen species"}, {"id": "GO:0009636", "name": "response to toxic substance"}, {"id": "GO:0019430", "name": "removal of superoxide radicals"}, {"id": "GO:0006801", "name": "superoxide metabolic process"}, {"id": "GO:0006979", "name": "response to oxidative stress"}, {"id": "GO:0070887", "name": "cellular response to chemical stimulus"}, {"id": "GO:0042221", "name": "response to chemical"}, {"id": "GO:0071451", "name": "cellular response to superoxide"}, {"id": "GO:0008152", "name": "metabolic process"}, {"id": "GO:0009987", "name": "cellular process"}, {"id": "GO:0097237", "name": "cellular response to toxic substance"}, {"id": "GO:0000305", "name": "response to oxygen radical"}]}, {"annotation_id": "GO:0004601", "name": "peroxidase activity", "provenance_source": "UNIPROT", "type": "GO", "annotation_lineage": [{"id": "GO:0004601", "name": "peroxidase activity"}, {"id": "GO:0016491", "name": "oxidoreductase activity"}, {"id": "GO:0016209", "name": "antioxidant activity"}, {"id": "GO:0016684", "name": "oxidoreductase activity, acting on peroxide as acceptor"}, {"id": "GO:0003674", "name": "molecular_function"}, {"id": "GO:0003824", "name": "catalytic activity"}]}, {"annotation_id": "GO:0070062", "name": "extracellular exosome", "provenance_source": "UNIPROT", "type": "GO", "annotation_lineage": [{"id": "GO:0070062", "name": "extracellular exosome"}, {"id": "GO:0043227", "name": "membrane-bounded organelle"}, {"id": "GO:1903561", "name": "extracellular vesicle"}, {"id": "GO:0110165", "name": "cellular anatomical structure"}, {"id": "GO:0005575", "name": "cellular_component"}, {"id": "GO:0043230", "name": "extracellular organelle"}, {"id": "GO:0005576", "name": "extracellular region"}, {"id": "GO:0043226", "name": "organelle"}, {"id": "GO:0005615", "name": "extracellular space"}, {"id": "GO:0031982", "name": "vesicle"}, {"id": "GO:0065010", "name": "extracellular membrane-bounded organelle"}]}, {"annotation_id": "GO:0043066", "name": "negative regulation of apoptotic process", "provenance_source": "UNIPROT", "type": "GO", "annotation_lineage": [{"id": "GO:0050789", "name": "regulation of biological process"}, {"id": "GO:0050794", "name": "regulation of cellular process"}, {"id": "GO:0043069", "name": "negative regulation of programmed cell death"}, {"id": "GO:0042981", "name": "regulation of apoptotic process"}, {"id": "GO:0065007", "name": "biological regulation"}, {"id": "GO:0048519", "name": "negative regulation of biological process"}, {"id": "GO:0043067", "name": "regulation of programmed cell death"}, {"id": "GO:0008219", "name": "cell death"}, {"id": "GO:0043066", "name": "negative regulation of apoptotic process"}, {"id": "GO:0048523", "name": "negative regulation of cellular process"}, {"id": "GO:0008150", "name": "biological_process"}, {"id": "GO:0009987", "name": "cellular process"}, {"id": "GO:0006915", "name": "apoptotic process"}, {"id": "GO:0012501", "name": "programmed cell death"}]}, {"annotation_id": "GO:0001878", "name": "response to yeast", "provenance_source": "UNIPROT", "type": "GO", "annotation_lineage": [{"id": "GO:0044419", "name": "biological process involved in interspecies interaction between organisms"}, {"id": "GO:0050896", "name": "response to stimulus"}, {"id": "GO:0051707", "name": "response to other organism"}, {"id": "GO:0001878", "name": "response to yeast"}, {"id": "GO:0008150", "name": "biological_process"}, {"id": "GO:0009605", "name": "response to external stimulus"}, {"id": "GO:0009620", "name": "response to fungus"}, {"id": "GO:0043207", "name": "response to external biotic stimulus"}, {"id": "GO:0009607", "name": "response to biotic stimulus"}]}, {"annotation_id": "GO:0002149", "name": "hypochlorous acid biosynthetic process", "provenance_source": "UNIPROT", "type": "GO", "annotation_lineage": [{"id": "GO:1903409", "name": "reactive oxygen species biosynthetic process"}, {"id": "GO:0009058", "name": "biosynthetic process"}, {"id": "GO:0044283", "name": "small molecule biosynthetic process"}, {"id": "GO:0043436", "name": "oxoacid metabolic process"}, {"id": "GO:0002149", "name": "hypochlorous acid biosynthetic process"}, {"id": "GO:0072593", "name": "reactive oxygen species metabolic process"}, {"id": "GO:0008150", "name": "biological_process"}, {"id": "GO:0044281", "name": "small molecule metabolic process"}, {"id": "GO:0008152", "name": "metabolic process"}, {"id": "GO:0009987", "name": "cellular process"}, {"id": "GO:0006082", "name": "organic acid metabolic process"}]}, {"annotation_id": "GO:0003682", "name": "chromatin binding", "provenance_source": "UNIPROT", "type": "GO", "annotation_lineage": [{"id": "GO:0003682", "name": "chromatin binding"}, {"id": "GO:0005488", "name": "binding"}, {"id": "GO:0003674", "name": "molecular_function"}]}, {"annotation_id": "GO:0043231", "name": "intracellular membrane-bounded organelle", "provenance_source": "UNIPROT", "type": "GO", "annotation_lineage": [{"id": "GO:0043227", "name": "membrane-bounded organelle"}, {"id": "GO:0043229", "name": "intracellular organelle"}, {"id": "GO:0110165", "name": "cellular anatomical structure"}, {"id": "GO:0005575", "name": "cellular_component"}, {"id": "GO:0005622", "name": "intracellular anatomical structure"}, {"id": "GO:0043226", "name": "organelle"}, {"id": "GO:0043231", "name": "intracellular membrane-bounded organelle"}]}, {"annotation_id": "GO:0030141", "name": "secretory granule", "provenance_source": "UNIPROT", "type": "GO", "annotation_lineage": [{"id": "GO:0043227", "name": "membrane-bounded organelle"}, {"id": "GO:0005575", "name": "cellular_component"}, {"id": "GO:0005622", "name": "intracellular anatomical structure"}, {"id": "GO:0097708", "name": "intracellular vesicle"}, {"id": "GO:0043231", "name": "intracellular membrane-bounded organelle"}, {"id": "GO:0012505", "name": "endomembrane system"}, {"id": "GO:0043229", "name": "intracellular organelle"}, {"id": "GO:0110165", "name": "cellular anatomical structure"}, {"id": "GO:0031410", "name": "cytoplasmic vesicle"}, {"id": "GO:0043226", "name": "organelle"}, {"id": "GO:0030141", "name": "secretory granule"}, {"id": "GO:0099503", "name": "secretory vesicle"}, {"id": "GO:0005737", "name": "cytoplasm"}, {"id": "GO:0031982", "name": "vesicle"}]}, {"annotation_id": "GO:0035578", "name": "azurophil granule lumen", "provenance_source": "UNIPROT", "type": "GO", "annotation_lineage": [{"id": "GO:0043227", "name": "membrane-bounded organelle"}, {"id": "GO:0005575", "name": "cellular_component"}, {"id": "GO:0005622", "name": "intracellular anatomical structure"}, {"id": "GO:0000323", "name": "lytic vacuole"}, {"id": "GO:0097708", "name": "intracellular vesicle"}, {"id": "GO:0031974", "name": "membrane-enclosed lumen"}, {"id": "GO:0060205", "name": "cytoplasmic vesicle lumen"}, {"id": "GO:0005775", "name": "vacuolar lumen"}, {"id": "GO:0012505", "name": "endomembrane system"}, {"id": "GO:0070013", "name": "intracellular organelle lumen"}, {"id": "GO:0043229", "name": "intracellular organelle"}, {"id": "GO:0110165", "name": "cellular anatomical structure"}, {"id": "GO:0031410", "name": "cytoplasmic vesicle"}, {"id": "GO:0031982", "name": "vesicle"}, {"id": "GO:0005764", "name": "lysosome"}, {"id": "GO:0031983", "name": "vesicle lumen"}, {"id": "GO:0042582", "name": "azurophil granule"}, {"id": "GO:0005773", "name": "vacuole"}, {"id": "GO:0043231", "name": "intracellular membrane-bounded organelle"}, {"id": "GO:0034774", "name": "secretory granule lumen"}, {"id": "GO:0035578", "name": "azurophil granule lumen"}, {"id": "GO:0043233", "name": "organelle lumen"}, {"id": "GO:0043226", "name": "organelle"}, {"id": "GO:0030141", "name": "secretory granule"}, {"id": "GO:0005766", "name": "primary lysosome"}, {"id": "GO:0099503", "name": "secretory vesicle"}, {"id": "GO:0005737", "name": "cytoplasm"}]}, {"annotation_id": "GO:0042742", "name": "defense response to bacterium", "provenance_source": "UNIPROT", "type": "GO", "annotation_lineage": [{"id": "GO:0042742", "name": "defense response to bacterium"}, {"id": "GO:0044419", "name": "biological process involved in interspecies interaction between organisms"}, {"id": "GO:0050896", "name": "response to stimulus"}, {"id": "GO:0051707", "name": "response to other organism"}, {"id": "GO:0006952", "name": "defense response"}, {"id": "GO:0009617", "name": "response to bacterium"}, {"id": "GO:0006950", "name": "response to stress"}, {"id": "GO:0008150", "name": "biological_process"}, {"id": "GO:0009605", "name": "response to external stimulus"}, {"id": "GO:0043207", "name": "response to external biotic stimulus"}, {"id": "GO:0009607", "name": "response to biotic stimulus"}]}, {"annotation_id": "GO:0005654", "name": "nucleoplasm", "provenance_source": "UNIPROT", "type": "GO", "annotation_lineage": [{"id": "GO:0043227", "name": "membrane-bounded organelle"}, {"id": "GO:0005575", "name": "cellular_component"}, {"id": "GO:0005622", "name": "intracellular anatomical structure"}, {"id": "GO:0005634", "name": "nucleus"}, {"id": "GO:0031974", "name": "membrane-enclosed lumen"}, {"id": "GO:0043231", "name": "intracellular membrane-bounded organelle"}, {"id": "GO:0070013", "name": "intracellular organelle lumen"}, {"id": "GO:0043229", "name": "intracellular organelle"}, {"id": "GO:0110165", "name": "cellular anatomical structure"}, {"id": "GO:0005654", "name": "nucleoplasm"}, {"id": "GO:0043233", "name": "organelle lumen"}, {"id": "GO:0043226", "name": "organelle"}, {"id": "GO:0031981", "name": "nuclear lumen"}]}, {"annotation_id": "GO:0005764", "name": "lysosome", "provenance_source": "UNIPROT", "type": "GO", "annotation_lineage": [{"id": "GO:0043227", "name": "membrane-bounded organelle"}, {"id": "GO:0043229", "name": "intracellular organelle"}, {"id": "GO:0110165", "name": "cellular anatomical structure"}, {"id": "GO:0005575", "name": "cellular_component"}, {"id": "GO:0005622", "name": "intracellular anatomical structure"}, {"id": "GO:0043226", "name": "organelle"}, {"id": "GO:0000323", "name": "lytic vacuole"}, {"id": "GO:0005773", "name": "vacuole"}, {"id": "GO:0005737", "name": "cytoplasm"}, {"id": "GO:0043231", "name": "intracellular membrane-bounded organelle"}, {"id": "GO:0005764", "name": "lysosome"}]}, {"annotation_id": "GO:0006952", "name": "defense response", "provenance_source": "UNIPROT", "type": "GO", "annotation_lineage": [{"id": "GO:0050896", "name": "response to stimulus"}, {"id": "GO:0006952", "name": "defense response"}, {"id": "GO:0006950", "name": "response to stress"}, {"id": "GO:0008150", "name": "biological_process"}]}, {"annotation_id": "GO:0097013", "name": "phagocytic vesicle lumen", "provenance_source": "UNIPROT", "type": "GO", "annotation_lineage": [{"id": "GO:0097013", "name": "phagocytic vesicle lumen"}, {"id": "GO:0043227", "name": "membrane-bounded organelle"}, {"id": "GO:0005575", "name": "cellular_component"}, {"id": "GO:0005622", "name": "intracellular anatomical structure"}, {"id": "GO:0097708", "name": "intracellular vesicle"}, {"id": "GO:0031974", "name": "membrane-enclosed lumen"}, {"id": "GO:0045335", "name": "phagocytic vesicle"}, {"id": "GO:0043231", "name": "intracellular membrane-bounded organelle"}, {"id": "GO:0070013", "name": "intracellular organelle lumen"}, {"id": "GO:0043229", "name": "intracellular organelle"}, {"id": "GO:0110165", "name": "cellular anatomical structure"}, {"id": "GO:0031410", "name": "cytoplasmic vesicle"}, {"id": "GO:0043233", "name": "organelle lumen"}, {"id": "GO:0043226", "name": "organelle"}, {"id": "GO:0071682", "name": "endocytic vesicle lumen"}, {"id": "GO:0005737", "name": "cytoplasm"}, {"id": "GO:0031982", "name": "vesicle"}, {"id": "GO:0030139", "name": "endocytic vesicle"}]}, {"annotation_id": "IPR037120", "name": "Haem peroxidase domain superfamily, animal type", "provenance_source": "UNIPROT", "type": "InterPro", "annotation_lineage": [{"id": "IPR037120", "name": "Haem peroxidase domain superfamily, animal type"}]}, {"annotation_id": "GO:1990268", "name": "response to gold nanoparticle", "provenance_source": "UNIPROT", "type": "GO", "annotation_lineage": [{"id": "GO:1990267", "name": "response to transition metal nanoparticle"}, {"id": "GO:0050896", "name": "response to stimulus"}, {"id": "GO:1990268", "name": "response to gold nanoparticle"}, {"id": "GO:0042221", "name": "response to chemical"}, {"id": "GO:0008150", "name": "biological_process"}]}, {"annotation_id": "GO:0009612", "name": "response to mechanical stimulus", "provenance_source": "UNIPROT", "type": "GO", "annotation_lineage": [{"id": "GO:0050896", "name": "response to stimulus"}, {"id": "GO:0009612", "name": "response to mechanical stimulus"}, {"id": "GO:0008150", "name": "biological_process"}, {"id": "GO:0009628", "name": "response to abiotic stimulus"}, {"id": "GO:0009605", "name": "response to external stimulus"}]}, {"annotation_id": "GO:0005576", "name": "extracellular region", "provenance_source": "UNIPROT", "type": "GO", "annotation_lineage": [{"id": "GO:0110165", "name": "cellular anatomical structure"}, {"id": "GO:0005575", "name": "cellular_component"}, {"id": "GO:0005576", "name": "extracellular region"}]}, {"annotation_id": "GO:0020037", "name": "heme binding", "provenance_source": "UNIPROT", "type": "GO", "annotation_lineage": [{"id": "GO:0005488", "name": "binding"}, {"id": "GO:0046906", "name": "tetrapyrrole binding"}, {"id": "GO:0020037", "name": "heme binding"}, {"id": "GO:0003674", "name": "molecular_function"}]}, {"annotation_id": "GO:0050832", "name": "defense response to fungus", "provenance_source": "UNIPROT", "type": "GO", "annotation_lineage": [{"id": "GO:0050832", "name": "defense response to fungus"}, {"id": "GO:0044419", "name": "biological process involved in interspecies interaction between organisms"}, {"id": "GO:0050896", "name": "response to stimulus"}, {"id": "GO:0051707", "name": "response to other organism"}, {"id": "GO:0006952", "name": "defense response"}, {"id": "GO:0006950", "name": "response to stress"}, {"id": "GO:0008150", "name": "biological_process"}, {"id": "GO:0009605", "name": "response to external stimulus"}, {"id": "GO:0009620", "name": "response to fungus"}, {"id": "GO:0043207", "name": "response to external biotic stimulus"}, {"id": "GO:0009607", "name": "response to biotic stimulus"}]}, {"annotation_id": "GO:0042582", "name": "azurophil granule", "provenance_source": "UNIPROT", "type": "GO", "annotation_lineage": [{"id": "GO:0043227", "name": "membrane-bounded organelle"}, {"id": "GO:0005575", "name": "cellular_component"}, {"id": "GO:0005622", "name": "intracellular anatomical structure"}, {"id": "GO:0000323", "name": "lytic vacuole"}, {"id": "GO:0097708", "name": "intracellular vesicle"}, {"id": "GO:0042582", "name": "azurophil granule"}, {"id": "GO:0005773", "name": "vacuole"}, {"id": "GO:0043231", "name": "intracellular membrane-bounded organelle"}, {"id": "GO:0012505", "name": "endomembrane system"}, {"id": "GO:0043229", "name": "intracellular organelle"}, {"id": "GO:0110165", "name": "cellular anatomical structure"}, {"id": "GO:0031410", "name": "cytoplasmic vesicle"}, {"id": "GO:0043226", "name": "organelle"}, {"id": "GO:0030141", "name": "secretory granule"}, {"id": "GO:0005766", "name": "primary lysosome"}, {"id": "GO:0099503", "name": "secretory vesicle"}, {"id": "GO:0005737", "name": "cytoplasm"}, {"id": "GO:0031982", "name": "vesicle"}, {"id": "GO:0005764", "name": "lysosome"}]}, {"annotation_id": "IPR010255", "name": "Haem peroxidase superfamily", "provenance_source": "UNIPROT", "type": "InterPro", "annotation_lineage": [{"id": "IPR010255", "name": "Haem peroxidase superfamily"}]}, {"annotation_id": "GO:0006979", "name": "response to oxidative stress", "provenance_source": "UNIPROT", "type": "GO", "annotation_lineage": [{"id": "GO:0006979", "name": "response to oxidative stress"}, {"id": "GO:0050896", "name": "response to stimulus"}, {"id": "GO:0006950", "name": "response to stress"}, {"id": "GO:0008150", "name": "biological_process"}]}, {"annotation_id": "GO:0002679", "name": "respiratory burst involved in defense response", "provenance_source": "UNIPROT", "type": "GO", "annotation_lineage": [{"id": "GO:0045730", "name": "respiratory burst"}, {"id": "GO:0002679", "name": "respiratory burst involved in defense response"}, {"id": "GO:0050896", "name": "response to stimulus"}, {"id": "GO:0006952", "name": "defense response"}, {"id": "GO:0002376", "name": "immune system process"}, {"id": "GO:0006950", "name": "response to stress"}, {"id": "GO:0008150", "name": "biological_process"}, {"id": "GO:0008152", "name": "metabolic process"}, {"id": "GO:0009987", "name": "cellular process"}, {"id": "GO:0002252", "name": "immune effector process"}]}, {"annotation_id": "GO:0005615", "name": "extracellular space", "provenance_source": "UNIPROT", "type": "GO", "annotation_lineage": [{"id": "GO:0110165", "name": "cellular anatomical structure"}, {"id": "GO:0005575", "name": "cellular_component"}, {"id": "GO:0005576", "name": "extracellular region"}, {"id": "GO:0005615", "name": "extracellular space"}]}, {"annotation_id": "GO:0032496", "name": "response to lipopolysaccharide", "provenance_source": "UNIPROT", "type": "GO", "annotation_lineage": [{"id": "GO:0044419", "name": "biological process involved in interspecies interaction between organisms"}, {"id": "GO:0050896", "name": "response to stimulus"}, {"id": "GO:0033993", "name": "response to lipid"}, {"id": "GO:0051707", "name": "response to other organism"}, {"id": "GO:1901700", "name": "response to oxygen-containing compound"}, {"id": "GO:0009605", "name": "response to external stimulus"}, {"id": "GO:0032496", "name": "response to lipopolysaccharide"}, {"id": "GO:0009607", "name": "response to biotic stimulus"}, {"id": "GO:0009617", "name": "response to bacterium"}, {"id": "GO:0042221", "name": "response to chemical"}, {"id": "GO:0008150", "name": "biological_process"}, {"id": "GO:0043207", "name": "response to external biotic stimulus"}, {"id": "GO:0002237", "name": "response to molecule of bacterial origin"}]}, {"annotation_id": "GO:0032094", "name": "response to food", "provenance_source": "UNIPROT", "type": "GO", "annotation_lineage": [{"id": "GO:0031667", "name": "response to nutrient levels"}, {"id": "GO:0050896", "name": "response to stimulus"}, {"id": "GO:0032094", "name": "response to food"}, {"id": "GO:0042221", "name": "response to chemical"}, {"id": "GO:0008150", "name": "biological_process"}]}, {"annotation_id": "GO:0046872", "name": "metal ion binding", "provenance_source": "UNIPROT", "type": "GO", "annotation_lineage": [{"id": "GO:0043169", "name": "cation binding"}, {"id": "GO:0043167", "name": "ion binding"}, {"id": "GO:0005488", "name": "binding"}, {"id": "GO:0003674", "name": "molecular_function"}, {"id": "GO:0046872", "name": "metal ion binding"}, {"id": "GO:0036094", "name": "small molecule binding"}]}, {"annotation_id": "GO:0005634", "name": "nucleus", "provenance_source": "UNIPROT", "type": "GO", "annotation_lineage": [{"id": "GO:0043227", "name": "membrane-bounded organelle"}, {"id": "GO:0043229", "name": "intracellular organelle"}, {"id": "GO:0110165", "name": "cellular anatomical structure"}, {"id": "GO:0005575", "name": "cellular_component"}, {"id": "GO:0005622", "name": "intracellular anatomical structure"}, {"id": "GO:0043226", "name": "organelle"}, {"id": "GO:0005634", "name": "nucleus"}, {"id": "GO:0043231", "name": "intracellular membrane-bounded organelle"}]}, {"annotation_id": "GO:0008201", "name": "heparin binding", "provenance_source": "UNIPROT", "type": "GO", "annotation_lineage": [{"id": "GO:0008201", "name": "heparin binding"}, {"id": "GO:0005539", "name": "glycosaminoglycan binding"}, {"id": "GO:0005488", "name": "binding"}, {"id": "GO:0097367", "name": "carbohydrate derivative binding"}, {"id": "GO:0003674", "name": "molecular_function"}, {"id": "GO:1901681", "name": "sulfur compound binding"}]}], "rcsb_polymer_entity_container_identifiers": {"asym_ids": ["A", "C"], "auth_asym_ids": ["A", "B"], "chem_comp_monomers": ["ALA", "ARG", "ASN", "ASP", "CYS", "GLN", "GLU", "GLY", "HIS", "ILE", "LEU", "LYS", "MET", "PHE", "PRO", "SER", "THR", "TRP", "TYR", "VAL"], "entity_id": "1", "entry_id": "1MHL", "rcsb_id": "1MHL_1", "uniprot_ids": ["P05164"], "reference_sequence_identifiers": [{"database_accession": "P05164", "database_name": "UniProt", "entity_sequence_coverage": 1.0, "provenance_source": "SIFTS", "reference_sequence_coverage": 0.14496644295302014}]}, "rcsb_polymer_entity_feature": [{"name": "Hydropathy values", "provenance_source": "biojava-7.2.4", "type": "hydropathy", "feature_positions": [{"beg_seq_id": 5, "values": [-1.26, -2.22, -2.22, -2.0, -1.9, -1.56, -0.96, -0.29, -0.24, -0.49, -0.49, -0.91, -1.5, -1.6, -1.63, -1.42, -1.74, -1.16, -0.86, -0.74, -0.74, -0.46, 0.03, 0.58, -0.34, -0.4, -0.18, -0.27, 0.32, 0.43, 0.09, -0.61, -1.47, -1.01, -0.6, -1.11, -0.51, -0.89, -0.64, -0.54, -0.26, 0.06, -0.08, -0.43, 0.12, -0.73, -1.06, -1.3, -1.3, -0.89, -0.99, -0.34, -0.1, -0.14, 0.49, 0.49, 1.08, 1.59, 1.19, 0.98, 0.12, 0.42, 0.47, -0.23, 0.58, 0.2, -0.34, -0.64, -0.64, 0.17, -0.41, -1.06, -0.94, -1.64, -1.86, -2.28, -1.98, -1.17, -1.38, -0.99, -0.6, -0.6, -0.31, 0.03, 0.14, 0.66, 0.66, 0.06, -0.61, -1.21, -0.4, -0.69, -0.33, -0.02, -0.62, -1.43, -1.22, -0.67, -0.08, -1.0]}]}, {"name": "Disordered regions", "provenance_source": "IUPred2(short)", "type": "disorder", "feature_positions": [{"beg_seq_id": 1, "values": [0.89, 0.81, 0.77, 0.73, 0.68, 0.55, 0.51, 0.47, 0.42, 0.38, 0.33, 0.39, 0.39, 0.43, 0.41, 0.38, 0.38, 0.37, 0.36, 0.41, 0.35, 0.3, 0.36, 0.28, 0.22, 0.27, 0.32, 0.33, 0.24, 0.25, 0.27, 0.27, 0.17, 0.17, 0.16, 0.17, 0.13, 0.13, 0.08, 0.08, 0.1, 0.15, 0.13, 0.13, 0.18, 0.23, 0.22, 0.18, 0.2, 0.23, 0.2, 0.15, 0.13, 0.18, 0.17, 0.17, 0.16, 0.24, 0.25, 0.26, 0.19, 0.17, 0.11, 0.19, 0.19, 0.22, 0.23, 0.15, 0.22, 0.23, 0.3, 0.34, 0.42, 0.44, 0.45, 0.4, 0.44, 0.37, 0.34, 0.35, 0.33, 0.41, 0.43, 0.45, 0.35, 0.36, 0.34, 0.35, 0.36, 0.38, 0.27, 0.26, 0.29, 0.29, 0.33, 0.31, 0.36, 0.38, 0.49, 0.55, 0.58, 0.7, 0.73, 0.75, 0.84, 0.92, 0.93, 0.96]}]}, {"name": "Disordered binding sites", "provenance_source": "Anchor2", "type": "disorder_binding", "feature_positions": [{"beg_seq_id": 1, "values": [0.43, 0.43, 0.42, 0.42, 0.41, 0.41, 0.41, 0.4, 0.4, 0.39, 0.39, 0.38, 0.38, 0.38, 0.38, 0.37, 0.37, 0.37, 0.36, 0.36, 0.37, 0.37, 0.38, 0.39, 0.4, 0.42, 0.43, 0.42, 0.41, 0.4, 0.38, 0.38, 0.37, 0.37, 0.37, 0.37, 0.37, 0.37, 0.37, 0.37, 0.38, 0.38, 0.37, 0.38, 0.39, 0.39, 0.4, 0.41, 0.41, 0.42, 0.43, 0.43, 0.42, 0.41, 0.41, 0.41, 0.42, 0.42, 0.42, 0.42, 0.43, 0.42, 0.42, 0.41, 0.41, 0.41, 0.41, 0.41, 0.41, 0.41, 0.41, 0.42, 0.43, 0.43, 0.43, 0.43, 0.42, 0.42, 0.41, 0.41, 0.4, 0.4, 0.4, 0.39, 0.39, 0.38, 0.38, 0.37, 0.37, 0.37, 0.37, 0.37, 0.37, 0.38, 0.38, 0.39, 0.39, 0.4, 0.4, 0.4, 0.41, 0.41, 0.41, 0.41, 0.4, 0.4, 0.4, 0.4]}]}], "rcsb_polymer_entity_group_membership": [{"aggregation_method": "sequence_identity", "group_id": "746_90", "similarity_cutoff": 90.0, "aligned_regions": [{"entity_beg_seq_id": 1, "length": 108, "ref_beg_seq_id": 165}]}, {"aggregation_method": "sequence_identity", "group_id": "1044_70", "similarity_cutoff": 70.0, "aligned_regions": [{"entity_beg_seq_id": 1, "length": 108, "ref_beg_seq_id": 165}]}, {"aggregation_method": "sequence_identity", "group_id": "1424_30", "similarity_cutoff": 30.0, "aligned_regions": [{"entity_beg_seq_id": 1, "length": 5, "ref_beg_seq_id": 165}, {"entity_beg_seq_id": 6, "length": 103, "ref_beg_seq_id": 173}]}, {"aggregation_method": "sequence_identity", "group_id": "571_100", "similarity_cutoff": 100.0, "aligned_regions": [{"entity_beg_seq_id": 1, "length": 108, "ref_beg_seq_id": 165}]}, {"aggregation_method": "matching_uniprot_accession", "group_id": "P05164", "aligned_regions": [{"entity_beg_seq_id": 1, "length": 108, "ref_beg_seq_id": 165}]}, {"aggregation_method": "sequence_identity", "group_id": "728_50", "similarity_cutoff": 50.0, "aligned_regions": [{"entity_beg_seq_id": 1, "length": 4, "ref_beg_seq_id": 165}, {"entity_beg_seq_id": 5, "length": 104, "ref_beg_seq_id": 172}]}, {"aggregation_method": "sequence_identity", "group_id": "697_95", "similarity_cutoff": 95.0, "aligned_regions": [{"entity_beg_seq_id": 1, "length": 108, "ref_beg_seq_id": 165}]}], "rcsb_related_target_references": [{"related_resource_name": "ChEMBL", "related_resource_version": "36", "related_target_id": "CHEMBL2439", "target_taxonomy_id": 9606, "aligned_target": [{"entity_beg_seq_id": 1, "length": 107, "target_beg_seq_id": 165}]}, {"related_resource_name": "DrugBank", "related_resource_version": "5.1", "related_target_id": "P05164", "target_taxonomy_id": 9606, "aligned_target": [{"entity_beg_seq_id": 1, "length": 107, "target_beg_seq_id": 165}]}, {"related_resource_name": "Pharos", "related_resource_version": "6.13.4", "related_target_id": "10818", "target_taxonomy_id": 9606, "aligned_target": [{"entity_beg_seq_id": 1, "length": 107, "target_beg_seq_id": 165}]}], "rcsb_target_cofactors": [{"binding_assay_value": 2.7, "binding_assay_value_type": "pEC50", "cofactor_in_ch_ikey": "LCMYHRLGWJEHSA-NHPMDPCJSA-N", "cofactor_smiles": "CSCC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](N)Cc1cccs1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C(N)N)C(=O)O", "cofactor_resource_id": "CHEMBL127385", "neighbor_flag": "N", "resource_name": "ChEMBL", "resource_version": "36", "target_resource_id": "CHEMBL2439"}, {"binding_assay_value": 2.7, "binding_assay_value_type": "pIC50", "cofactor_in_ch_ikey": "BSYNRYMUTXBXSQ-UHFFFAOYSA-N", "cofactor_smiles": "CC(=O)Oc1ccccc1C(=O)O", "cofactor_chem_comp_id": "AIN", "cofactor_name": "ASPIRIN", "cofactor_resource_id": "CHEMBL25", "mechanism_of_action": "Cyclooxygenase inhibitor", "neighbor_flag": "N", "resource_name": "ChEMBL", "resource_version": "36", "target_resource_id": "CHEMBL2439"}, {"binding_assay_value": 2.5, "binding_assay_value_type": "pIC50", "cofactor_in_ch_ikey": "FRIWTGPMPWVNBD-SNVBAGLBSA-N", "cofactor_smiles": "Fc1ccc2[nH]c([C@@H]3CCN(CC4NC=CN4)C3)nc2c1", "cofactor_resource_id": "CHEMBL4064328", "neighbor_flag": "N", "resource_name": "ChEMBL", "resource_version": "36", "target_resource_id": "CHEMBL2439"}, {"binding_assay_value": 2.48, "binding_assay_value_type": "pEC50", "cofactor_in_ch_ikey": "AOVXWGGECSBEAF-DMTKBSSASA-N", "cofactor_smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C(N)N)C(=O)O", "cofactor_resource_id": "CHEMBL408929", "neighbor_flag": "N", "resource_name": "ChEMBL", "resource_version": "36", "target_resource_id": "CHEMBL2439"}, {"binding_assay_value": 1.77, "binding_assay_value_type": "pIC50", "cofactor_in_ch_ikey": "FHQDBJHRQZGYOZ-UHFFFAOYSA-N", "cofactor_smiles": "Nc1ccc(Oc2cc(Cl)c(Cl)cc2Cl)cn1", "cofactor_resource_id": "CHEMBL4282403", "neighbor_flag": "N", "resource_name": "ChEMBL", "resource_version": "36", "target_resource_id": "CHEMBL2439"}, {"cofactor_in_ch_ikey": "OIRCOABEOLEUMC-GEJPAHFPSA-N", "cofactor_smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](N)CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O", "cofactor_name": "Bivalirudin", "cofactor_resource_id": "DB00006", "mechanism_of_action": "Inhibits the action of thrombin by binding both to its catalytic site and to its anion-binding exosite. Thrombin is a serine proteinase that plays a central role in the thrombotic process, acting to cleave fibrinogen into fibrin monomers and to activate Factor XIII to Factor XIIIa, allowing fibrin to develop a covalently cross-linked framework which stabilizes the thrombus; thrombin also activates Factors V and VIII, promoting further thrombin generation, and activates platelets, stimulating aggregation and granule release.", "neighbor_flag": "N", "pubmed_ids": [18701766], "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "P05164"}, {"cofactor_name": "Octreotide", "cofactor_resource_id": "DB00104", "mechanism_of_action": "Octreotide binds to somatostatin receptors coupled to phospholipase C through G proteins and leads to smooth muscle contraction in the blood vessels.[L14519] Downstream effects that stimulate phospholipase C, the production of 1, 4,5-inositol triphosphate, and action on the L-type calcium channels lead to the inhibition of growth hormone, treating the various growth-hormone and metabolic effects of acromegaly.[L14519]\r\n\r\nOctreotide's suppression of luteinizing hormone (LH)[A214724], reduction in splanchnic blood flow[A214727], and inhibition of serotonin, gastrin, vasoactive intestinal peptide, secretin, motilin, and pancreatic polypeptide provide relief for the gastrointestinal and flushing symptoms of carcinoid and/or VIPoma tumors.[A214721]", "neighbor_flag": "N", "pubmed_ids": [10929949, 11020872], "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "P05164"}, {"cofactor_in_ch_ikey": "AUNGANRZJHBGPY-SCRDCRAPSA-N", "cofactor_smiles": "CC1=C(C)C=C2N(C[C@H](O)[C@H](O)[C@H](O)CO)C3=NC(=O)NC(=O)C3=NC2=C1", "cofactor_chem_comp_id": "RBF", "cofactor_name": "Riboflavin", "cofactor_resource_id": "DB00140", "mechanism_of_action": "Binds to riboflavin hydrogenase, riboflavin kinase, and riboflavin synthase. Riboflavin is the precursor of flavin mononucleotide (FMN, riboflavin monophosphate) and flavin adenine dinucleotide (FAD). The antioxidant activity of riboflavin is principally derived from its role as a precursor of FAD and the role of this cofactor in the production of the antioxidant reduced glutathione. Reduced glutathione is the cofactor of the selenium-containing glutathione peroxidases among other things. The glutathione peroxidases are major antioxidant enzymes. Reduced glutathione is generated by the FAD-containing enzyme glutathione reductase.", "neighbor_flag": "N", "pubmed_ids": [37713619], "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "P05164"}, {"cofactor_in_ch_ikey": "PHWBOXQYWZNQIN-UHFFFAOYSA-N", "cofactor_smiles": "ClC1=CC=CC=C1CN1CCC2=C(C1)C=CS2", "cofactor_chem_comp_id": "TIC", "cofactor_name": "Ticlopidine", "cofactor_resource_id": "DB00208", "mechanism_of_action": "The active metabolite of ticlopidine prevents binding of adenosine diphosphate (ADP) to its platelet receptor, impairing the ADP-mediated activation of the glycoprotein GPIIb/IIIa complex. It is proposed that the inhibition involves a defect in the mobilization from the storage sites of the platelet granules to the outer membrane. No direct interference occurs with the GPIIb/IIIa receptor. As the glycoprotein GPIIb/IIIa complex is the major receptor for fibrinogen, its impaired activation prevents fibrinogen binding to platelets and inhibits platelet aggregation. By blocking the amplification of platelet activation by released ADP, platelet aggregation induced by agonists other than ADP is also inhibited by the active metabolite of ticlopidine.", "neighbor_flag": "N", "pubmed_ids": [19515014], "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "P05164"}, {"cofactor_in_ch_ikey": "WUBBRNOQWQTFEX-UHFFFAOYSA-N", "cofactor_smiles": "NC1=CC(O)=C(C=C1)C(O)=O", "cofactor_chem_comp_id": "BHA", "cofactor_name": "Aminosalicylic acid", "cofactor_resource_id": "DB00233", "mechanism_of_action": "There are two mechanisms responsible for aminosalicylic acid's bacteriostatic action against <i>Mycobacterium tuberculosis</i>. Firstly, aminosalicylic acid inhibits folic acid synthesis (without potentiation with antifolic compounds). The binding of para-aminobenzoic acid to pteridine synthetase acts as the first step in folic acid synthesis. Aminosalicylic acid binds pteridine synthetase with greater affinity than para-aminobenzoic acid, effectively inhibiting the synthesis of folic acid. As bacteria are unable to use external sources of folic acid, cell growth and multiplication slows. Secondly, aminosalicylic acid may inhibit the synthesis of the cell wall component, mycobactin, thus reducing iron uptake by <i>M. tuberculosis</i>.", "neighbor_flag": "N", "pubmed_ids": [2563347, 16614956], "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "P05164"}, {"cofactor_in_ch_ikey": "MQJKPEGWNLWLTK-UHFFFAOYSA-N", "cofactor_smiles": "NC1=CC=C(C=C1)S(=O)(=O)C1=CC=C(N)C=C1", "cofactor_name": "Dapsone", "cofactor_resource_id": "DB00250", "mechanism_of_action": "Dapsone acts against bacteria and protozoa in the same way as sulphonamides, that is by inhibiting the synthesis of dihydrofolic acid through competition with para-amino-benzoate for the active site of dihydropteroate synthetase. The anti-inflammatory action of the drug is unrelated to its antibacterial action and is still not fully understood.", "neighbor_flag": "N", "pubmed_ids": [19515014, 30466896, 39574417], "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "P05164"}, {"cofactor_in_ch_ikey": "BLXXJMDCKKHMKV-UHFFFAOYSA-N", "cofactor_smiles": "COC1=CC2=C(C=C1)C=C(CCC(C)=O)C=C2", "cofactor_chem_comp_id": "NBO", "cofactor_name": "Nabumetone", "cofactor_resource_id": "DB00461", "mechanism_of_action": "Nabumetone's active metabolite, 6-MNA, is an inhibitor of both COX-1 and COX-2 although it exhibits some COX-2 selectivity.[label,A178903] Inhibition of COX-1 and COX-2 reduces conversion of arachidonic acid to PGs and thromboxane (TXA<sub>2</sub>). This reduction in prostanoid production is the common mechanism that mediates the effects of nambutone.\r\n\r\nPGE<sub>2</sub> is the primary PG involved in modulation of nociception.[A179023] It mediates peripheral sensitization through a variety of effects.[T116,A179023] PGE<sub>2</sub> activates the G<sub>q</sub>-coupled EP<sub>1</sub> receptor leading to increased activity of the inositol trisphosphate/phospholipase C pathway. Activation of this pathway releases intracellular stores of calcium which directly reduces action potential threshold and activates protein kinase C (PKC) which contributes to several indirect mechanisms. PGE<sub>2</sub> also activates the EP<sub>4</sub> receptor, coupled to G<sub>s</sub>, which activates the adenylyl cyclase/protein kinase A (AC/PKA) signaling pathway. PKA and PKC both contribute to the potentiation of transient receptor potential cation channel subfamily V member 1 (TRPV1) potentiation, which increases sensitivity to heat stimuli. They also activate tetrodotoxin-resistant sodium channels and inhibit inward potassium currents. PKA further contributes to the activation of the P2X3 purine receptor and sensitization of T-type calcium channels. The activation and sensitization of depolarizing ion channels and inhibition of inward potassium currents serve to reduce the intensity of stimulus necessary to generate action potentials in nociceptive sensory afferents. PGE<sub>2</sub> act via EP<sub>3</sub> to increase sensitivity to bradykinin and via EP<sub>2</sub> to further increase heat sensitivity. Central sensitization occurs in the dorsal horn of the spinal cord and is mediated by the EP<sub>2</sub> receptor which couples to G<sub>s</sub>. Pre-synaptically, this receptor increases the release of pro-nociceptive neurotransmitters glutamate, CGRP, and substance P. Post-synaptically it increases the activity of AMPA and NMDA receptors and produces inhibition of inhibitory glycinergic neurons. Together these lead to a reduced threshold of activating, allowing low intensity stimuli to generate pain signals. PGI<sub>2</sub> is known to play a role via its G<sub>s</sub>-coupled IP receptor although the magnitude of its contribution varies. It has been proposed to be of greater importance in painful inflammatory conditions such as arthritis. By limiting sensitization, both peripheral and central, via these pathways NSAIDs can effectively reduce inflammatory pain.\r\n\r\nPGI<sub>2</sub> and PGE<sub>2</sub> contribute to acute inflammation via their IP and EP<sub>2</sub> receptors.[T116,A179044] Similarly to \u03b2 adrenergic receptors these are G<sub>s</sub>-coupled and mediate vasodilation through the AC/PKA pathway. PGE<sub>2</sub> also contributes by increasing leukocyte adhesion to the endothelium and attracts the cells to the site of injury.[T116] PGD<sub>2</sub> plays a role in the activation of endothelial cell release of cytokines through its DP<sub>1</sub> receptor.[A179044] PGI<sub>2</sub> and PGE<sub>2</sub> modulate T-helper cell activation and differentiation through IP, EP<sub>2</sub>, and EP<sub>4</sub> receptors which is believed to be an important activity in the pathology of arthritic conditions. By limiting the production of these PGs at the site of injury, NSAIDs can reduce inflammation.\r\n\r\nPGE<sub>2</sub> can cross the blood-brain barrier and act on excitatory G<sub>q</sub> EP<sub>3</sub> receptors on thermoregulatory neurons in the hypothalamus.[T116] This activation triggers an increase in heat-generation and a reduction in heat-loss to produce a fever. NSAIDs prevent the generation of PGE<sub>2</sub> thereby reducing the activity of these neurons.\r\n\r\nThe adverse effects of NSAIDs stem from the protective and regulatory roles of prostanoids which have been well-characterized.[T116] PGI<sub>2</sub> and PGE<sub>2</sub> regulate blood flow to the kidney by similar mechanisms to the vasodilation they produce in inflammation. Prevention of this regulation by NSAIDs produces vasoconstriction which limits renal function by reducing blood flow and the hydrostatic pressure which drives filtration. PGE<sub>2</sub> also regulates gastric protection via EP<sub>3</sub> receptors which are, in this location, coupled to G<sub>i</sub> which inhibits the AC/PKA pathway. This reduces the secretion of protons by H<sup>+</sup>/K<sup>+</sup> ATPase in parietal cells and increases the secretion of mucus and HCO<sub>3</sub><sup>-</sup> by superficial endothelial cells. Disruption of this protective action by NSAIDs lead to ulceration of the gastric mucosa. Lastly, disruption of PGI<sub>2</sub>, which opposes platelet aggregation, generation by COX-2 selective agents leads to an imbalance with TXA<sub>2</sub> generated by COX-1, which promotes aggregation of platelets, leading to increased risk of thrombosis. Since nabumetone is somewhat COX-2 selective it is thought to promote this imbalance and increase thrombotic risk.[A178903]", "neighbor_flag": "N", "pubmed_ids": [10503773], "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "P05164"}, {"cofactor_in_ch_ikey": "UPSPUYADGBWSHF-UHFFFAOYSA-N", "cofactor_smiles": "CN1C(CC(O)=O)=CC=C1C(=O)C1=CC=C(C)C=C1", "cofactor_chem_comp_id": "TLT", "cofactor_name": "Tolmetin", "cofactor_resource_id": "DB00500", "mechanism_of_action": "The mode of action of tolmetin is not known. However, studies in laboratory animals and man have demonstrated that the anti-inflammatory action of tolmetin is not due to pituitary-adrenal stimulation. Tolmetin inhibits prostaglandin synthetase in vitro and lowers the plasma level of prostaglandin E in man. This reduction in prostaglandin synthesis may be responsible for the anti-inflammatory action. Tolmetin does not appear to alter the course of the underlying disease in man.", "neighbor_flag": "N", "pubmed_ids": [6266970], "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "P05164"}, {"cofactor_in_ch_ikey": "LXZZYRPGZAFOLE-UHFFFAOYSA-L", "cofactor_smiles": "[H][N]([H])([H])[Pt](Cl)(Cl)[N]([H])([H])[H]", "cofactor_chem_comp_id": "CPT", "cofactor_name": "Cisplatin", "cofactor_resource_id": "DB00515", "mechanism_of_action": "Alkylating agents work by three different mechanisms: 1) attachment of alkyl groups to DNA bases, resulting in the DNA being fragmented by repair enzymes in their attempts to replace the alkylated bases, preventing DNA synthesis and RNA transcription from the affected DNA, 2) DNA damage via the formation of cross-links (bonds between atoms in the DNA) which prevents DNA from being separated for synthesis or transcription, and 3) the induction of mispairing of the nucleotides leading to mutations.", "neighbor_flag": "N", "pubmed_ids": [19818462, 14745844], "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "P05164"}, {"cofactor_in_ch_ikey": "ZROHGHOFXNOHSO-BNTLRKBRSA-L", "cofactor_smiles": "[H][N]1([H])[C@@H]2CCCC[C@H]2[N]([H])([H])[Pt]11OC(=O)C(=O)O1", "cofactor_name": "Oxaliplatin", "cofactor_resource_id": "DB00526", "mechanism_of_action": "Oxaliplatin undergoes nonenzymatic conversion in physiologic solutions to active derivatives via displacement of the labile oxalate ligand. Several transient reactive species are formed, including monoaquo and diaquo DACH platinum, which covalently bind with macromolecules. Both inter and intrastrand Pt-DNA crosslinks are formed. Crosslinks are formed between the N7 positions of two adjacent guanines (GG), adjacent adenine-guanines (AG), and guanines separated by an intervening nucleotide (GNG). These crosslinks inhibit DNA replication and transcription. Cytotoxicity is cell-cycle nonspecific.[L47206]\r\n\r\n", "neighbor_flag": "N", "pubmed_ids": [29056657], "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "P05164"}, {"cofactor_in_ch_ikey": "RTXOFQZKPXMALH-GHXIOONMSA-N", "cofactor_smiles": "[H][C@]12SCC(C=C)=C(N1C(=O)[C@H]2NC(=O)C(=N/O)\\C1=CSC(N)=N1)C(O)=O", "cofactor_name": "Cefdinir", "cofactor_resource_id": "DB00535", "mechanism_of_action": "Five-member thiazolidine rings that make up penicillins are replaced in cephalosporins by a six-member dihydrothiazine ring, conferring greater bactericidal activity. This 6-member ring enables cefdinir and other cephalosporins to resist inactivation by certain bacterial enzymes.[A180772]\r\n\r\nWith a mechanism similar to other beta-lactam antibiotics, the bactericidal activity of cefdinir is caused by the inhibition of cell wall synthesis via binding to penicillin-binding proteins (PBPs). Cefdinir, like other cephalosporins, penetrates the bacterial cell wall, combats inactivation by beta-lactamase enzymes, and inactivates penicillin-binding proteins.[A180772] This interferes with the final step of transpeptidation in cell walls, eventually leading to cell lysis, which eventually leads to the death of bacteria that are susceptible to this drug.[A180724] Cefdinir has shown affinity to penicillin protein binding proteins 2 and 3. [A15746,A180760,A15747] It has also been shown to inhibit transpeptidase enzymes of various bacteria, which may play a role in its bactericidal action.[A180766,A180769] One in vitro study suggests that cefdinir inhibits myeloperoxidase release extracellularly.[A11897] The impact of this potential drug target in relation to its mechanism of action is unknown.", "neighbor_flag": "N", "pubmed_ids": [8133056], "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "P05164"}, {"cofactor_in_ch_ikey": "KNAHARQHSZJURB-UHFFFAOYSA-N", "cofactor_smiles": "CCCC1=CC(=O)NC(=S)N1", "cofactor_chem_comp_id": "3CJ", "cofactor_name": "Propylthiouracil", "cofactor_resource_id": "DB00550", "mechanism_of_action": "Propylthiouracil binds to thyroid peroxidase and thereby inhibits the conversion of iodide to iodine. Thyroid peroxidase normally converts iodide to iodine (via hydrogen peroxide as a cofactor) and also catalyzes the incorporation of the resulting iodide molecule onto both the 3 and/or 5 positions of the phenol rings of tyrosines found in thyroglobulin. Thyroglobulin is degraded to produce thyroxine (T4) and tri-iodothyronine (T3), which are the main hormones produced by the thyroid gland. Therefore propylthiouracil effectively inhibits the production of new thyroid hormones.", "neighbor_flag": "N", "pubmed_ids": [2159305, 6096612, 17070108, 2837228, 26509551, 39574417], "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "P05164"}, {"cofactor_in_ch_ikey": "PHIQHXFUZVPYII-ZCFIWIBFSA-N", "cofactor_smiles": "C[N+](C)(C)C[C@H](O)CC([O-])=O", "cofactor_name": "Levocarnitine", "cofactor_resource_id": "DB00583", "mechanism_of_action": "Levocarnitine can be synthesised within the body from the amino acids lysine or methionine. Vitamin C (ascorbic acid) is essential to the synthesis of carnitine. Levocarnitine is a carrier molecule in the transport of long chain fatty acids across the inner mitochondrial membrane. It also exports acyl groups from subcellular organelles and from cells to urine before they accumulate to toxic concentrations. Only the L isomer of carnitine (sometimes called vitamin BT) affects lipid metabolism. Levocarnitine is handled by several proteins in different pathways including carnitine transporters, carnitine translocases, carnitine acetyltransferases and carnitine palmitoyltransferases.", "neighbor_flag": "N", "pubmed_ids": [16130180], "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "P05164"}, {"cofactor_in_ch_ikey": "QYIYFLOTGYLRGG-GPCCPHFNSA-N", "cofactor_smiles": "[H][C@]12SCC(Cl)=C(N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=CC=C1)C(O)=O", "cofactor_chem_comp_id": "8XI", "cofactor_name": "Cefaclor", "cofactor_resource_id": "DB00833", "mechanism_of_action": "Cefaclor, like the penicillins, is a beta-lactam antibiotic. By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, it inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins. It is possible that cefaclor interferes with an autolysin inhibitor.", "neighbor_flag": "N", "pubmed_ids": [11675909], "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "P05164"}, {"cofactor_in_ch_ikey": "UFULAYFCSOUIOV-UHFFFAOYSA-N", "cofactor_smiles": "NCCS", "cofactor_chem_comp_id": "DHL", "cofactor_name": "Cysteamine", "cofactor_resource_id": "DB00847", "mechanism_of_action": "Individuals born without the ability to metabolize cystine suffer from cystinosis, a rare genetic disorder characterized by the widespread accumulation of cystine crystals throughout the body and eye tissues. The cystine crystals may cause considerable damage, particularly in the renal tissues and corneal tissues. In some cases, renal failure can occur during childhood if the condition is left untreated. Other organs that may be affected by cystinosis include the CNS, thyroid, pancreas, muscle tissues, and gonads.[A218721] \r\n\r\nCysteamine converts cystine to cysteine and cysteine-cysteamine mixed disulfides, reducing the buildup of corneal cystine crystals.[L15611] This drug participates in a thiol-disulfide interchange reaction with lysosomes, leading to cysteine exit from the lysosome in patients diagnosed with cystinosis.[L15616]", "neighbor_flag": "N", "pubmed_ids": [2852004, 8381104, 2829860], "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "P05164"}, {"cofactor_in_ch_ikey": "OLESAACUTLOWQZ-UHFFFAOYSA-L", "cofactor_smiles": "[H][N]([H])([H])[Pt]1(OC(=O)C2(CCC2)C(=O)O1)[N]([H])([H])[H]", "cofactor_name": "Carboplatin", "cofactor_resource_id": "DB00958", "mechanism_of_action": "Carboplatin predominantly acts by attaching alkyl groups to the nucleotides, leading to the formation of monoadducts, and DNA fragmenting when repair enzymes attempt to correct the error.[A230158,L32253] 2% of carboplatin's activity comes from DNA cross-linking from a base on one strand to a base on another, preventing DNA strands from separating for synthesis or transcription.[A230158,A1472] Finally, carboplatin can induce a number of different mutations.[A230158]", "neighbor_flag": "N", "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "P05164"}, {"cofactor_in_ch_ikey": "DRLFMBDRBRZALE-UHFFFAOYSA-N", "cofactor_smiles": "COC1=CC2=C(NC=C2CCNC(C)=O)C=C1", "cofactor_chem_comp_id": "ML1", "cofactor_name": "Melatonin", "cofactor_resource_id": "DB01065", "mechanism_of_action": "Melatonin is a derivative of tryptophan. It binds to melatonin receptor type 1A, which then acts on adenylate cylcase and the inhibition of a cAMP signal transduction pathway. Melatonin not only inhibits adenylate cyclase, but it also activates phosphilpase C. This potentiates the release of arachidonate. By binding to melatonin receptors 1 and 2, the downstream signallling cascades have various effects in the body. The melatonin receptors are G protein-coupled receptors and are expressed in various tissues of the body. There are two subtypes of the receptor in humans, melatonin receptor 1 (MT1) and melatonin receptor 2 (MT2). Melatonin and melatonin receptor agonists, on market or in clinical trials, all bind to and activate both receptor types.The binding of the agonists to the receptors has been investigated for over two decades or since 1986. It is somewhat known, but still not fully understood. When melatonin receptor agonists bind to and activate their receptors it causes numerous physiological processes.\r\nMT1 receptors are expressed in many regions of the central nervous system (CNS): suprachiasmatic nucleus of the hypothalamus (SNC), hippocampus, substantia nigra, cerebellum, central dopaminergic pathways, ventral tegmental area and nucleus accumbens. MT1 is also expressed in the retina, ovary, testis, mammary gland, coronary circulation and aorta, gallbladder, liver, kidney, skin and the immune system. MT2 receptors are expressed mainly in the CNS, also in the lung, cardiac, coronary and aortic tissue, myometrium and granulosa cells, immune cells, duodenum and adipocytes.\r\nThe binding of melatonin to melatonin receptors activates a few signaling pathways. MT1 receptor activation inhibits the adenylyl cyclase and its inhibition causes a rippling effect of non activation; starting with decreasing formation of cyclic adenosine monophosphate (cAMP), and then progressing to less protein kinase A (PKA) activity, which in turn hinders the phosphorilation of cAMP responsive element-binding protein (CREB binding protein) into P-CREB. MT1 receptors also activate phospholipase C (PLC), affect ion channels and regulate ion flux inside the cell. The binding of melatonin to MT2 receptors inhibits adenylyl cyclase which decreases the formation of cAMP.[4] As well it hinders guanylyl cyclase and therefore the forming of cyclic guanosine monophosphate (cGMP). Binding to MT2 receptors probably affects PLC which increases protein kinase C (PKC) activity. Activation of the receptor can lead to ion flux inside the cell.", "neighbor_flag": "N", "pubmed_ids": [18237195], "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "P05164"}, {"cofactor_name": "Enoxaparin", "cofactor_resource_id": "DB01225", "mechanism_of_action": "Enoxaparin binds to antithrombin III, a serine protease inhibitor, forming a complex that irreversibly inactivates factor Xa, which is frequently used to monitor anticoagulation in the clinical setting.[A228318] Following factor Xa inactivation, enoxaparin is released and binds to other anti-thrombin molecules. Factor IIa (thrombin) is directly inhibited by enoxaparin, however with less potency than unfractionated heparin (UFH). [A188051] Due to the cascade of effects resulting from enoxaparin binding, thrombin is unable to convert fibrinogen to fibrin and form a clot, preventing thromboembolic events. \r\n \r\n", "neighbor_flag": "N", "pubmed_ids": [19049846, 11748259, 24837008], "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "P05164"}, {"cofactor_in_ch_ikey": "LWQQLNNNIPYSNX-UROSTWAQSA-N", "cofactor_smiles": "O[C@H](\\C=C\\[C@@H](C)[C@@]1([H])CC[C@@]2([H])\\C(CCC[C@]12C)=C\\C=C1\\C[C@@H](O)C[C@H](O)C1=C)C1CC1", "cofactor_chem_comp_id": "MC9", "cofactor_name": "Calcipotriol", "cofactor_resource_id": "DB02300", "mechanism_of_action": "The precise mechanism of calcipotriol in remitting psoriasis is not well-understood, however, it has been shown to have comparable affinity with calcitriol for the Vitamin D receptor while being less than 1% the activity in regulating calcium metabolism. The Vitamin D receptor (VDR) belongs to the steroid/thyroid receptor superfamily, and is found on the cells of many different tissues including the thyroid, bone, kindney, and T cells of the immune system. T cells are known to play a role in psoriasis and are believed to undergo modulation of gene expression with binding of calcipotriol to the VDR. This modulation is thought to affect gene products related to cell differentiation and proliferation.", "neighbor_flag": "N", "pubmed_ids": [12928540], "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "P05164"}, {"cofactor_in_ch_ikey": "XXPANQJNYNUNES-UHFFFAOYSA-N", "cofactor_smiles": "CN1CC(C2=CC=CC=C2)C2=C(C1)C(N)=CC=C2", "cofactor_name": "Nomifensine", "cofactor_resource_id": "DB04821", "neighbor_flag": "N", "pubmed_ids": [16679384], "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "P05164"}, {"cofactor_in_ch_ikey": "JOYRKODLDBILNP-UHFFFAOYSA-N", "cofactor_smiles": "CCOC(N)=O", "cofactor_name": "Urethane", "cofactor_resource_id": "DB04827", "neighbor_flag": "N", "pubmed_ids": [8941558], "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "P05164"}, {"cofactor_name": "Elafin", "cofactor_resource_id": "DB05161", "mechanism_of_action": "Elafin is able to abrogate lipopolysaccharide-induced production of monocyte chemotactic protein 1 in monocytes by inhibiting AP-1 and NFkappaB activation. Due to its selective expression at mucosal surfaces as well as in alveolar macrophages, monocytes and neutrophils, the ability of Elafin to inhibit the lipopolysaccharide signaling pathway may be important in disease states such as cystic fibrosis, pneumonia, and acute respiratory distress syndrome. The inhibition of two key inflammatory pathways confirms the importance of Elafin as a mediator of the innate immune response.", "neighbor_flag": "N", "pubmed_ids": [9049140], "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "P05164"}, {"cofactor_name": "AB192", "cofactor_resource_id": "DB06111", "neighbor_flag": "N", "pubmed_ids": [20018218], "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "P05164"}, {"cofactor_in_ch_ikey": "IWXNYAIICFKCTM-UHFFFAOYSA-N", "cofactor_smiles": "CC(C)C1=CC=C(C=C1S(C)(=O)=O)C(=O)NC(N)=N", "cofactor_chem_comp_id": "HG0", "cofactor_name": "Cariporide", "cofactor_resource_id": "DB06468", "mechanism_of_action": "Cariporide is a selective sodium-hydrogen antiporter inhibitor. The sodium-hydrogen exchanger is an importatn player in the pathophysiology of myocardial ischemia-referfusion injury. The accumulation of hydrogen ions in the myocyte cytoso; during ischemia creates a proton gradiant that promote the efflux of hydrogen ions in exchange for the influx of sodium ions. This sodium buildup can secondary activates the sodium-calcium exchanger to operate in the reverse mode, resulting in a net calcium accumulation in myocyte cytosol, which leads to dysfunction and cell death. By inhibiting sodium-hydrogen exchange, Cariporide can prevent the accumulation of calcium in cytosol, therefore reduce the infarct size.", "neighbor_flag": "N", "pubmed_ids": [19023020], "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "P05164"}, {"cofactor_in_ch_ikey": "YKPUWZUDDOIDPM-SOFGYWHQSA-N", "cofactor_smiles": "COC1=C(O)C=CC(CNC(=O)CCCC\\C=C\\C(C)C)=C1", "cofactor_chem_comp_id": "4DY", "cofactor_name": "Capsaicin", "cofactor_resource_id": "DB06774", "mechanism_of_action": "Capsaicin has been shown to reduce the amount of substance P associated with inflammation - however this is not believed to be its main mechanism in the relief of pain [A32319]. Capsaicin's mechanism of action is attributed to \"defunctionalization\" of nociceptor fibers by inducing a topical hypersensitivity reaction on the skin. This alteration in pain mechanisms is due to many of the following: temporary loss of membrane potential, inability to transport neurotrophic factors leading to altered phenotype, and reversible retraction of epidermal and dermal nerve fiber terminals. ", "neighbor_flag": "N", "pubmed_ids": [17874046, 11125845], "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "P05164"}, {"cofactor_in_ch_ikey": "YTGJWQPHMWSCST-UHFFFAOYSA-N", "cofactor_smiles": "CC(S)C(=O)NCC(O)=O", "cofactor_name": "Tiopronin", "cofactor_resource_id": "DB06823", "mechanism_of_action": "Kidney stones form when the solubility limit is exceeded and urine becomes supersaturated with endogenous cystine. Tiopronin is an active reducing agent which undergoes a thiol-disulfide exchange with cystine to form a water-soluble mixed disulfide complex. Thus, the amount of sparingly soluble cystine is reduced. By reducing urinary cystine concentrations below the solubility limit, tiopronin helps reduce cystine stone formation. ", "neighbor_flag": "N", "pubmed_ids": [2998407], "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "P05164"}, {"cofactor_in_ch_ikey": "FVJCUZCRPIMVLB-UHFFFAOYSA-N", "cofactor_smiles": "CC(C)OCCN1C2=C(NC=C2)C(=O)NC1=S", "cofactor_chem_comp_id": "W4Y", "cofactor_name": "Verdiperstat", "cofactor_resource_id": "DB12440", "neighbor_flag": "N", "pubmed_ids": [37713619, 32503688, 39574417], "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "P05164"}, {"cofactor_in_ch_ikey": "BHKKSKOHRFHHIN-MRVPVSSYSA-N", "cofactor_smiles": "C[C@@H](N)C1=CC(Cl)=CC=C1CN1C2=C(NC=C2)C(=O)NC1=S", "cofactor_name": "Mitiperstat", "cofactor_resource_id": "DB18963", "neighbor_flag": "N", "pubmed_ids": [37713619], "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "P05164"}, {"binding_assay_value": 9.0, "binding_assay_value_type": "pIC50", "cofactor_smiles": "Nc1cc([C@H](CCN[C@H]2C[C@@H](c3ccccc3)c3ccccc32)c2ccccc2)c2nn[nH]c2n1", "cofactor_resource_id": "CHEMBL4747269", "neighbor_flag": "N", "pubmed_ids": [33007547], "resource_name": "Pharos", "resource_version": "6.13.4", "target_resource_id": "10818"}, {"binding_assay_value": 9.0, "binding_assay_value_type": "pIC50", "cofactor_smiles": "Nc1cc([C@H](CCNC23CCC(c4ccccc4)(CC2)CC3)c2ccccc2)c2nn[nH]c2n1", "cofactor_resource_id": "CHEMBL4790231", "neighbor_flag": "N", "pubmed_ids": [33811992], "resource_name": "Pharos", "resource_version": "6.13.4", "target_resource_id": "10818"}, {"binding_assay_value": 8.7, "binding_assay_value_type": "pIC50", "cofactor_smiles": "Nc1cc([C@H](CCN[C@H]2CC[C@H](c3ccccc3)CC2)c2ccccc2)c2nn[nH]c2n1", "cofactor_resource_id": "CHEMBL4763667", "neighbor_flag": "N", "pubmed_ids": [33007547], "resource_name": "Pharos", "resource_version": "6.13.4", "target_resource_id": "10818"}, {"binding_assay_value": 8.54, "binding_assay_value_type": "pIC50", "cofactor_smiles": "Nc1cc([C@H](CCN[C@@H]2CC[C@@H](c3ccccc3)c3ccccc32)c2ccccc2)c2nn[nH]c2n1", "cofactor_resource_id": "CHEMBL4752248", "neighbor_flag": "N", "pubmed_ids": [33007547], "resource_name": "Pharos", "resource_version": "6.13.4", "target_resource_id": "10818"}, {"binding_assay_value": 8.52, "binding_assay_value_type": "pIC50", "cofactor_smiles": "NCCSCCc1c[nH]c2c(F)cccc12", "cofactor_resource_id": "CHEMBL2347170", "neighbor_flag": "N", "pubmed_ids": [23581551], "resource_name": "Pharos", "resource_version": "6.13.4", "target_resource_id": "10818"}, {"binding_assay_value": 8.4, "binding_assay_value_type": "pIC50", "cofactor_smiles": "NCCSCCc1c[nH]c2ccc(F)cc12", "cofactor_resource_id": "CHEMBL2347168", "neighbor_flag": "N", "pubmed_ids": [23581551], "resource_name": "Pharos", "resource_version": "6.13.4", "target_resource_id": "10818"}, {"binding_assay_value": 8.3, "binding_assay_value_type": "pIC50", "cofactor_smiles": "O=C(NO)c1c[nH]c(NCc2cc(C(F)(F)F)cc(C(F)(F)F)c2)nc1=O", "cofactor_chem_comp_id": "NIH", "cofactor_resource_id": "CHEMBL4068067", "neighbor_flag": "Y", "pubmed_ids": [28671460], "resource_name": "Pharos", "resource_version": "6.13.4", "target_resource_id": "10818"}, {"binding_assay_value": 8.05, "binding_assay_value_type": "pIC50", "cofactor_smiles": "O=c1[nH]c(=S)n(C[C@H]2CCCO2)c2nc[nH]c12", "cofactor_chem_comp_id": "UE8", "cofactor_resource_id": "CHEMBL4278946", "neighbor_flag": "Y", "pubmed_ids": [30108726], "resource_name": "Pharos", "resource_version": "6.13.4", "target_resource_id": "10818"}, {"binding_assay_value": 7.7, "binding_assay_value_type": "pIC50", "cofactor_smiles": "Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1", "cofactor_chem_comp_id": "8PR", "cofactor_resource_id": "CHEMBL490", "neighbor_flag": "Y", "pubmed_ids": [28671460], "resource_name": "Pharos", "resource_version": "6.13.4", "target_resource_id": "10818"}, {"binding_assay_value": 7.08, "binding_assay_value_type": "pIC50", "cofactor_smiles": "Nc1nc(OCc2ccccc2)c2[nH]nnc2n1", "cofactor_chem_comp_id": "AEY", "cofactor_resource_id": "CHEMBL333928", "neighbor_flag": "Y", "pubmed_ids": [30108726], "resource_name": "Pharos", "resource_version": "6.13.4", "target_resource_id": "10818"}], "rcsb_id": "1MHL_1"}